|
|
||||||||
secretion
Noll Physiological Research Center, Pennsylvania State University, University Park, Pennsylvania 16802-6900
| |
ABSTRACT |
|---|
|
|
|---|
Monocytes and macrophages are activated by various
environmental challenges, including microorganisms, radiation, and
pollutants. These cells release cytokines, such as interleukin
(IL)-1
, that mediate physiological adaptations to stress. This study
sought to define further the role of IL-1
in general adaptation to
environmental stress by testing the hypothesis that high altitude
(20,000 ft, 6,096 m) would stimulate IL-1
secretion from isolated
human blood mononuclear cells. Cells from six young men (aged
22-26 yr) were divided into separate cultures incubated in either
standard ambient conditions or in one of three test conditions,
hypobaric hypoxia (simulating 20,000 ft), hypobaric normoxia (20,000 ft, O2 supplemented), and normobaric hypoxia (10%
O2). This design allowed differentiation between
pressure-related vs. oxygen-related effects. Each subject made multiple
blood donations in order that cells from all subjects were tested in
all conditions. Contrary to the hypothesis, IL-1
secretion was not
induced at simulated altitude in basal cell cultures. In
lipopolysaccharide-stimulated cell cultures, exposure to altitude
inhibited IL-1
secretion by ~40%, and the inhibition was due to
the change in pressure (P = 0.039) rather than the change in oxygen. Secretion of other factors (IL-1 receptor antagonist and soluble IL-1 receptor type II) was not inhibited. Although these
results are in opposition to the original hypothesis, they provide
insight regarding adaptations necessary for hematopoiesis in response
to high altitude and also provide a cellular rationale for the mountain
sanatoriums of the 19th and early 20th centuries.
hypoxic; altitude; mononuclear cells
| |
INTRODUCTION |
|---|
|
|
|---|
BLOOD MONOCYTES AND
TISSUE macrophages are recognized as an early line of defense
against infectious microorganisms. They phagocytize microbes and other
foreign particulate matter, and they digest them with lytic enzymes and
reactive oxygen species. These cells also release inflammatory
cytokines such as interleukin (IL)-1
that promote both innate and
adaptive immune responses (5). IL-1
and other cytokines
orchestrate the "acute phase response" in which physiological
effectors, via generation of fever and hepatic production of plasma
proteins, produce an internal environment hostile to the invaders.
Furthermore, IL-1
and other cytokines induce heat shock proteins and
antioxidants in host cells that protect them against current and future
stresses (16). Several environmental challenges
(radiation, oxidative stress, and thermal injury) can induce IL-1
(5). These observations lead to the question: is the
release of IL-1
a generalized response to any environmental stress?
The present study was intended to test the hypothesis that the stresses
of high altitude would induce IL-1
secretion. However, the secretion
of IL-1
can be affected by physical exertion, stress-induced hormones (4), and other systemic factors that may change
on ascent to high altitudes or enclosure of a human subject in a pressure chamber (11). The present study sought to focus
on the direct effect of altitude on IL-1
-secreting cells and to separate the influence of reduced pressure from the influence of
reduced oxygen.
| |
METHODS |
|---|
|
|
|---|
Six male subjects were recruited (22-26 yr of age) who were moderately active and did not smoke. All subjects were requested not to participate in physical activities or drink alcohol for 24 h before blood samples were drawn. The subjects read and signed informed consent forms. All procedures were approved by The Pennsylvania State University Office for Regulatory Compliance.
With the use of a standard sterile technique, 30 ml of blood were drawn
into heparinized tubes, and the mononuclear cells were immediately
isolated using a Ficoll-hypaque density gradient (Histopaque, Sigma,
St. Louis, MO). Cells were resuspended at a final concentration of
2.5 × 106 cells/ml in RPMI 1640 media (Sigma)
supplemented with 2 mM L-glutamine, 100 U/ml penicillin,
100 µg/ml streptomycin, and 100 mM HEPES (all from Sigma). Cells were
cultured in two separate 24-well plates (Corning 3526, Corning). Each
well received 0.5 ml cell suspension and 10 µl heat-inactivated
autologous plasma. Control wells received an additional 0.5 ml of
supplemented RPMI, whereas stimulated wells received an additional 0.5 ml of supplemented RPMI containing lipopolysaccharide (LPS) from
Escherichia coli 055:B5 (Sigma), yielding a final LPS
concentration of 1 ng/ml. Plates were randomly assigned to control or
test environment and maintained there for 8 h. In one series of
experiments, cytochalasin B (Sigma) was added to the media (1 mM final
concentration), and associated control cultures were treated with
vehicle (0.1% DMSO in supplemented RPMI). At the end of the
environmental exposure, the supernatants were aspirated and frozen at
70°C.
IL-1
concentrations in the supernatants were measured in duplicate
with an ELISA kit (Cistron Biotechnology, Pine Brook, NJ). IL-1
receptor antagonist (IL-1RA) and soluble receptor type II
concentrations were assayed using sandwich ELISAs constructed with
commerially available reagents [antibodies and cytokine standards: R&D
Systems, Minneapolis, MN; streptavidin-conjugated horseradish peroxidase: Pierce, Rockford, IL; and
2,2'-azino-bis(3-ethylbenz-thiazoline-6-sulfonic acid): Sigma] as
previously described in detail (4). Absorbance at 405 nm
was measured with a Labsystems Multiskan MCC/340 plate reader (Needham
Heights, MA).
Three test environments and one standard control environment were
employed (see Table 1). The control
incubator was maintained at ambient pressure with a normal air-5%
CO2 environment and a 37°C temperature. For the test
environments, another incubator was placed in a room-sized
hypo-/hyperbaric chamber (Environmental Tectonics, Southampton,
PA). All environmental gases for this incubator were mixed in a 350-l
chain-compensated gasometer (Collins, Braintree, MA) located outside of
the chamber and pumped into the incubator at a flow rate of 200 ml/min. The gases were premixed before every experiment and
checked using an Applied Electrochemistry oxygen analyzer (model S-3A;
Sunnyvale, CA) and a Beckman carbon dioxide analyzer (model 864;
Schiller Park, IL) (see Table 1). The barometric pressure was
controlled by the chamber at 350 Torr (~20,000-ft altitude) for the
hypobaric condition.
|
Preliminary experiments were performed to verify that changes in the incubator environment caused by the different test conditions did not alter the temperature and pH of the media. A 24-well culture plate fitted with a miniature thermister (YSI Instruments, Yellow Springs, OH) and a Lazar miniature pH probe (model PHR-146) was used. All data were collected by computer (MAC IIcx) and logged using a LabView (National Instruments) program at 1-min intervals. No significant variations in temperature or pH (relative to ambient control) were observed under any of the experimental conditions.
The cytokine data were analyzed on a Macintosh G3 computer using
StatView software (SAS, Cary, NC). Differences between control and
experimental conditions (in cells from the same donor) were analyzed by
paired t-tests (Figs. 1, 3, and 4). Pressure-related vs.
oxygen-related differences were tested by two-way, repeated-measures ANOVA using experimental values normalized as percentages of control values (see Fig. 2).
|
|
| |
RESULTS |
|---|
|
|
|---|
IL-1
concentrations were below the detection limit of the assay
(10 pg/ml) for all unstimulated human mononuclear cell cultures (no
LPS) regardless of environmental condition (data not shown). Stimulation with 1 ng/ml LPS resulted in median IL-1
concentrations ranging between 1,350 and 1,750 pg/ml in the three repetitions of the
control condition (normobaric normoxia; Fig.
1).
Exposure of LPS-stimulated cells to the hypobaric hypoxia of 20,000 ft
caused consistent reductions in IL-1
secretion of >20% for all
subjects (P = 0.016; Fig. 1A). When
supplemented with oxygen, cells from four of six subjects still
responded to hypobaric conditions with >20% decreases in IL-1
secretion (P = 0.059; Fig. 1B). Hypoxia
under normobaric conditions had no effect on IL-1
secretion
(P = 0.758; Fig. 1C). Two-way,
repeated-measures ANOVA indicated that the change in pressure was the
significant factor influencing IL-1
secretion (P = 0.039; Fig. 2), and the change in oxygen
partial pressure was not a significant influence (P = 0.184). Treatment with cytochalasin B did not block the
altitude-induced reductions in IL-1
secretion (Fig.
3).
|
The biological activity of IL-1
is modulated by a naturally occuring
competitive inhibitor, IL-1RA, and by two types of soluble IL-1
receptors (sIL-1RI and sIL-1RII) produced by blood mononuclear cells.
In the present study, sufficient culture supernatant remained to allow
measurement of sIL-1RII for five subjects and IL-1RA for three
subjects. These factors were detectable in both unstimulated and
LPS-stimulated conditions. The hypobaric hypoxia of 20,000 ft did not
inhibit the secretion of either factor in unstimulated or
LPS-stimulated conditions (Fig. 4).
|
| |
DISCUSSION |
|---|
|
|
|---|
In this study, a simulated altitude of 20,000 ft caused a
significant reduction in IL-1
secretion. Altitude did not inhibit sIL-1RII or IL-1RA secretion, suggesting that the diminished IL-1
secretion is a specific, regulated response rather than a generalized depression of cellular function. Furthermore, the IL-1
response was
associated with reduced total barometric pressure rather than oxygen
partial pressure.
Hydrostatic pressure alters the passive permeability characteristics
and ATPase activity of cellular membranes (12). Exposure to high centrifugally applied hydrostatic pressure for 1 h caused changes in membrane lipid order and shedding of membrane proteins from
human red blood cell ghosts (1). The authors proposed that
the changes in membrane lipid order would influence phospholipid signaling and transmembrane transport. In another study, heart tissue
from rats exposed to chronic (30 day) hypobaric hypoxia (5,500 m, 380 Torr) exhibited reduced functional activity of G
s, although mRNA expression and protein concentrations for this signaling protein were unchanged (10). The authors
speculated that these functional changes may be due to alterations in
the association of G
s proteins with the plasma membrane cytoskeleton.
In the present study, normobaric hypoxia had no effect on IL-1
secretion (Fig. 1). These data are consistent with the conclusion of
Gerlach et al. (9) and others that the inflammatory
response seen in the hypoxia/ischemia of trauma and surgery is
predominately a function of reoxygenation. In support of this
contention, Matuschak and co-workers (15) inhibited
hypoxia/reoxygenation-induced IL-1 production in isolated, perfused
liver by treatment with antioxidant compounds, suggesting that the
inhibition was mediated by reactive oxygen species generated in the
reoxygenation phase. Nonetheless, the present study does not rule out a
potential influence of hypoxia in vivo. Alveolar macrophages may exist
in oxygen concentrations similar to those used in this study, but
circulating monocytes experience ~14% O2 in arterial
blood and ~5% O2 in venous blood (19).
Macrophages have been estimated to exist in an ~5% O2 environment in the spleen and somewhat lower oxygen tensions in the
liver (19). Scannell and associates (21)
reported that 9% O2 for up to 24 h caused no
significant change in tumor necrosis factor-
secretion by a monocyte
cell line, but 1% O2 was a significant stimulus.
If barometric pressure decreases rapidly, tiny bubbles of gas form in solution. These bubbles also form in the blood of divers who ascend to the surface too rapidly (the "bends" or decompression sickness) and in individuals who ascend too rapidly from sea level to extreme altitudes. Microbubbles have been observed in the blood of astronauts decompressing to altitude (200 Torr or ~38,000 ft) for space-suit operations (18). In the present study, formation of microbubbles in cell cultures and media alone (starting at 18,500 ft) was documented with a video camera attached to an inverted microscope. Microbubble formation, either internal or external to the cell, could be a mechanical stress on the cellular membrane causing the depressed IL-1 secretion. Microbubble interaction with platelets causes aggregation that is dependent on cAMP, but not products of cyclooxygenase or phospholipase C (13, 22).
In the present study, cytochalasin B was added to some cultures to
determine if cytoskeletal interactions were involved in the
pressure-related inhibition of IL-1
secretion. Low concentrations of
cytochalasin B do not disrupt existing microfilaments, but they prevent
f-actin polymerization (3). Thus the influence of
cytochalasin B will depend on the turnover rate of actin, which is
cell-type specific (6). Our experiment was predicated on the report that 1 mM cytochalasin B inhibited volume regulation of
murine peritoneal macrophages exposed to hypotonic stress
(8). In another study, 5 µM cytochalasin B inhibited
this response to hypotonic conditions in Jurkat cells (6).
In the present study, cytochalasin B (1 mM) had no effect on the human
mononuclear cell response to hypobaric stress, indicating that either
microfilament associations are not involved in the response or the
turnover rate was slow enough that existing microfilaments were
sufficient for a response.
The results of this investigation are diametrically opposed to the
original hypothesis. But, in retrospect, the altitude-induced decreases
in IL-1
secretion make sense in terms of physiological adaptation. A
principal component of altitude acclimatization is expansion of red
cell mass, which is mediated by erythropoietin. Frede et al.
(7) have reported that intraperitoneal injections of
IL-1
inhibited expression of renal erythropoietin mRNA in rats
exposed to normobaric hypoxia. In humans, recombinant erythropoietin therapy was less effective in multiple myeloma patients with high circulating IL-1
concentrations than those with low concentrations (17). Furthermore, IL-1
-mediated intracellular
sequestration of iron interferes with iron delivery to the bone marrow
for hemoglobin synthesis (2). Thus inhibition of IL-1
synthesis may facilitate erythropoiesis.
Perspectives
I have not at all the feeling of having really got acclimatized
The novel's protagonist Hans Castorp makes this statement
not long after arrival at a tuberculosis sanatorium in Davos,
Switzerland. In the middle to late 1800s, institutions situated at high
altitude such as Davos and Denver (The National Jewish Hospital) were
established for consumptives (tuberculosis patients). The purported
benefits of residence at altitude have been debated for decades, with
cool air temperature, low humidity, increased exposure to solar
radiation, cosmic radiation, ozone, and reduced atmospheric pressure
(from the standpoint of both hypoxia and the need for deeper
inspiration) considered as the critical elements (20). An
altitude-induced reduction in bacterial toxin-induced IL-1
secretion, as reported here, may have had the effect of reducing
symptoms, because IL-1
is a mediator of fever and cachexia. As
Hofrat Behrens, the directing physician of the sanatorium in The
Magic Mountain, commented: "Its curious about the metabolism of
protein with us up here. Although the process of combustion is
heightened, yet the body at the same time puts on flesh" [p. 47 (Ref. 14)].
| |
ACKNOWLEDGEMENTS |
|---|
This work was supported by the Marie Noll Graduate Fellowship and National Institutes of Health Grant RR-10732.
| |
FOOTNOTES |
|---|
Present address of W. J. Becker: Naval Medical Research Center, Bethesda, MD 20889.
Address for reprint requests and other correspondence: J. G. Cannon, 103 Noll Laboratory, Penn State Univ., Univ. Park, PA 16802-6900 (E-mail: jgc2{at}psu.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 21 November 2000; accepted in final form 2 February 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Barshtein, G,
Bergelson L,
Dagan A,
Gratton E,
and
Yedgar S.
Membrane lipid order of human red blood cells is altered by physiological levels of hydrostatic pressure.
Am J Physiol Heart Circ Physiol
272:
H538-H543,
1997
2.
Casadevall, N.
Cellular mechanism of resistance to erythropoietin.
Nephrol Dial Transplant
10, Suppl6:
27-30,
1995.
3.
Cooper, JA.
Effects of cytochalasin and phalloidin on actin.
J Cell Biol
105:
1473-1478,
1987
4.
Daun, JM,
Ball RW,
and
Cannon JG.
Glucocorticoid sensitivity of interleukin-1 agonist and antagonist secretion: the effects of age and gender.
Am J Physiol Regulatory Integrative Comp Physiol
278:
R855-R862,
2000
5.
Dinarello, CA.
Biologic basis for interleukin-1 in disease.
Blood
87:
2095-2147,
1996
6.
Downey, GP,
Grinstein S,
Sue-A-Quan A,
Czaban B,
and
Chan CK.
Volume regulation in leukocytes: requirement for an intact cytoskeleton.
J Cell Physiol
163:
96-104,
1995[ISI][Medline].
7.
Frede, S,
Fandrey J,
Pagel H,
Hellwig T,
and
Jelkmann W.
Erythropoietin gene expression is suppressed after lipopolysaccharide or interleukin-1
injections in rats.
Am J Physiol Regulatory Integrative Comp Physiol
273:
R1067-R1071,
1997
8.
Galkin, AA,
and
Khodorov BI.
The involvement of furosemide-sensitive ion cotransport system in the autoregulation of macrophage volume. Role of cytoskeleton.
Biol Membr
5:
302-307,
1988.
9.
Gerlach, H,
Gerlach M,
and
Clauss M.
Relevance of tumour necrosis factor-alpha and interleukin-1-alpha in the pathogenesis of hypoxia-related organ failure.
Eur J Anaesthesiol
10:
273-285,
1993[ISI][Medline].
10.
Kacimi, R,
Moalic JM,
Aldashev A,
Vatner DE,
Richalet JP,
and
Crozatier B.
Differential regulation of G protein expression in rat hearts exposed to chronic hypoxia.
Am J Physiol Heart Circ Physiol
269:
H1865-H1873,
1995
11.
Klokker, M,
Kharazmi A,
Galbo H,
Bygbjerg I,
and
Pedersen BK.
Influence of in vivo hypobaric hypoxia on function of lymphocytes, neutrocytes, natural killer cells, and cytokines.
J Appl Physiol
74:
1100-1106,
1993
12.
MacDonald, A.
The effects of pressure on the molecular structure and physiological functions of cell membranes.
Philos Trans R Soc Lond B Biol Sci
304:
47-68,
1984[ISI][Medline].
13.
Malmgren, R,
Thorsen T,
Nordvik A,
and
Holmsen H.
Microbubble-induced phospholipase C activation does not correlate with platelet aggregation.
Thromb Haemost
69:
394-396,
1993[ISI][Medline].
14.
Mann, T.
The Magic Mountain. Translated by H. T. Lowe-Porter. New York: Knopf, 1924.
15.
Matuschak, GM,
Johanns CA,
Chen Z,
Gaynor J,
and
Lechner AJ.
Brief hypoxic stress downregulates E. coli-induced IL-1
and IL-1
gene expression in perfused liver.
Am J Physiol Regulatory Integrative Comp Physiol
271:
R1311-R1318,
1996
16.
Moseley, PL.
Heat shock proteins and heat adaptation of the whole organism.
J Appl Physiol
83:
1413-1417,
1997
17.
Musto, P,
Falcone A,
D'Arena G,
Scalzulli PR,
Matera R,
Minervini MM,
Lombardi GF,
Modoni S,
Longo A,
and
Carotenuto M.
Clinical results of recombinant erythropoietin in transfusion-dependent patients with refractory multiple myeloma: role of cytokines and monitoring of erythropoiesis.
Eur J Haematol
58:
314-319,
1997[ISI][Medline].
18.
Nicogossian, A,
Huntoon C,
and
Pool S.
Space Physiology and Medicine. Philadelphia: Lea & Febiger, 1995.
19.
Noth, U,
Morrissey SP,
Deichmann R,
Adolf H,
Schwarzenbauer C,
Lutz J,
and
Haase A.
In vivo measurement of partial oxygen pressure in large vessels and in the reticuloendothelial system using fast 19F-MRI.
Magn Reson Med
34:
738-745,
1995[ISI][Medline].
20.
Rogers, FB.
The rise and decline of the altitude therapy of tuberculosis.
Bull Hist Med
43:
1-16,
1969[Medline].
21.
Scannell, G,
Waxman K,
Kaml GJ,
Ioli G,
Gatanaga T,
Yamamoto R,
and
Granger GA.
Hypoxia induces a human macrophage cell line to release tumor necrosis factor-alpha and its soluble receptors in vitro.
J Surg Res
54:
281-285,
1993[ISI][Medline].
22.
Thorsen, T,
Klausen H,
Lie RT,
and
Holmsen H.
Bubble-induced aggregation of platelets: effects of gas species, proteins, and decompression.
Undersea Hyperb Med
20:
101-119,
1993[ISI][Medline].
This article has been cited by other articles:
![]() |
H. Scholz Adaptational responses to hypoxia Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1541 - R1543. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |